DLA Piper
We only have limited information for this firm. Consider the following firms which have provided more information:
DLA Piper leverages its international network to assist its clients with EU marketing authorisations, data transparency, and mandates concerning the public procurement of medicines. Dividing his time between Brussels and Rome, Marco de Morpurgo leads the team, regularly advising on sector specific behavioural and compliance related matters; he is also known for his extensive knowledge of national and EU regulations governing the pharma and biotech industries.
Legal 500 Editorial commentary
Key clients
- Medtronic
- Sanofi
Abbreviated data is displayed for this firm.
Work highlights
- Assisted argenx BV with setting up a global distribution network for its autoimmune disease products. This involved reviewing distribution agreements in over 25 jurisdictions, and ensuring compliance with EU competition law.
- Advising Iovance Biotherapeutics on its acquisition of worldwide rights to Proleukin from Clinigen LImited, with a £166.7m upfront payment and potential milestone payments and royalties.
Abbreviated data is displayed for this firm.